Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,260.00
+16.00 (0.71%)
Sep 18, 2026, 4:59 PM CET
Genmab Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Genmab stock has a consensus rating of "Buy" and an average price target of kr 2,454. The average 1-year stock price forecast is 8.57% higher than the current stock price, while the lowest is kr 1,400 (-38.05%) and the highest is kr 2,930 (+29.65%).
Price Target: kr 2,454 (+8.57%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 11 | 13 | 13 | 13 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 18 | 18 | 18 |
Financial Forecast
Revenue This Year
4.58B
from 3.72B
Increased by 23.09%
Revenue Next Year
5.31B
from 4.58B
Increased by 16.07%
EPS This Year
13.07
from 17.72
Decreased by -26.23%
EPS Next Year
17.23
from 13.07
Increased by 31.78%
EPS and Forward PE are based on non-GAAP adjusted numbers.